Could a drug combo free liver transplant patients from lifelong pills?
NCT ID NCT06832189
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 29 times
Summary
This study tests whether two drugs, everolimus and epoetin, can help liver transplant recipients safely stop taking their standard anti-rejection medication (tacrolimus). The goal is to achieve 'operational tolerance,' where the body accepts the new liver without needing lifelong drugs. Twenty adults who are 1-10 years post-transplant and stable on tacrolimus will be enrolled. The main focus is safety, checking for infections, cancers, and serious side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER TRANSPLANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Northwestern University Feinberg School of Medicine
RECRUITINGChicago, Illinois, 60611, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of California San Francisco School of Medicine
RECRUITINGSan Francisco, California, 94143, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Pennsylvania Medical Center
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.